Stock BRETEC BIORETEC OY
Add to a list
To use this feature you must be a member
Log inSign up

Bioretec Oy Stock

Equities

BRETEC

FI4000480454

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Helsinki
Other stock markets
 11:20:50 2024-05-31 am EDT 		5-day change 1st Jan Change
2.6 EUR -2.26% Intraday chart for Bioretec Oy -2.26% +8.33%
May. 21 Medical Device Company Bioretec Names New CEO MT
May. 20 Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer CI

Financials

Sales 2023 3.91M 4.24M Sales 2024 * 5.3M 5.75M Capitalization 52.88M 57.34M
Net income 2023 -3M -3.25M Net income 2024 * -3M -3.25M EV / Sales 2023 13.5 x
Net cash position 2023 * 5.8M 6.29M Net cash position 2024 * 2.2M 2.39M EV / Sales 2024 * 9.56 x
P/E ratio 2023
-13.7 x
P/E ratio 2024 *
-16.3 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 64.37%
More Fundamentals * Assessed data

Chart Bioretec Oy

Dynamic Chart

Latest news about Bioretec Oy

Medical Device Company Bioretec Names New CEO MT
Bioretec Ltd. Announces Transfer of Timo Lehtonen from CEO to Chief Technology Officer CI
Bioretec Ltd Announces CEO Changes CI
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors CI
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition MT
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition CI
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant MT
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage CI
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2 MT
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation CI
Bioretec to Initiate Search for New CEO MT
Bioretec Ltd Announces CEO Changes CI
Bioretec Estimates the Approval of the European Market Authorization for the Biodegradable RemeOs? Trauma Screw Will Move to the First Quarter of 2024 CI
Bioretec Secures Distribution Agreement for Trauma Screws in US Market MT
Bioretec Signs Distribution Deal for Launch of Orthopedic Product in US MT
More news

Press releases Bioretec Oy

Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings - Ilmarinen Mutual Pension Insurance Company AQ
Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (Stephen Industries Inc Oy) AQ
Inside information: Alan Donze has been appointed as Bioretec's new CEO AQ
Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses AQ
Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors AQ
More press releases

Quotes and Performance

1 day-2.26%
1 week-2.26%
1 month+0.39%
3 months+15.56%
6 months+15.04%
Current year+8.33%
More quotes

Highs and lows

1 week
2.57
Extreme 2.57
2.69
1 month
2.46
Extreme 2.46
2.78
Current year
2.14
Extreme 2.14
2.90
1 year
2.02
Extreme 2.02
2.90
3 years
1.25
Extreme 1.245
3.75
5 years
1.25
Extreme 1.245
3.75
10 years
1.25
Extreme 1.245
3.75
More quotes

Managers and Directors - Bioretec Oy

Managers TitleAgeSince
Johanna Maarit Salko DFI
 Director of Finance/CFO 57 21-01-31
Tomi Juhani Numminen CHM
 Chairman 53 16-04-30
Esa Hallinen COO
 Chief Operating Officer 57 23-08-06
Members of the board TitleAgeSince
Tomi Juhani Numminen CHM
 Chairman 53 16-04-30
Pekka Ilmari Simula BRD
 Director/Board Member 50 19-12-31
Michael Piccirillo BRD
 Director/Board Member 65 17-12-31
More insiders

Quotes

Date Price Change Volume
24-05-31 2.6 -2.26% 13,221
24-05-30 2.66 +0.38% 5,198
24-05-29 2.65 -0.38% 5,315
24-05-28 2.66 -.--% 1,288
24-05-27 2.66 -.--% 6,380

Delayed Quote Nasdaq Helsinki, May 31, 2024 at 11:20 am EDT

More quotes

Company Profile

Bioretec Oy is a Finland-based medical device manufacturer company focusing on the development of strong, safe and reliable bioresorbable implants for pediatric and adult orthopedics. The Company operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-08-14 - Q2 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Ratings for Bioretec Oy

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.6 EUR
Average target price
3.85 EUR
Spread / Average Target
+48.08%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
BIORETEC OY Stock Bioretec Oy
+8.33% 57.34M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+75.69% 12.57B
PENUMBRA, INC. Stock Penumbra, Inc.
-24.68% 7.34B
MASIMO CORPORATION Stock Masimo Corporation
+6.22% 6.61B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+12.58% 5.39B
APT MEDICAL INC. Stock APT Medical Inc.
+26.90% 4.53B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.14% 3.91B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-22.99% 2.91B
NOVOCURE LIMITED Stock NovoCure Limited
+47.42% 2.37B
SKAN GROUP AG Stock SKAN Group AG
-0.37% 2B
Medical Equipment
  1. Stock Market
  2. Equities
  3. BRETEC Stock